Trial Profile
Observational Study Evaluating the Safety and Efficacy of Desloratadine Syrup for Perennial Allergic Rhinitis in Indonesian Pediatric Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Desloratadine (Primary)
- Indications Perennial allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Organon; Schering-Plough
- 21 Jul 2008 New trial record.